secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001171843-24-001695
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology FY2023 revenue $1.78M, net loss $14M, EPS -$3.48
--------------------------------------------------------------------

- Net loss of ~$14M on total revenue of ~$1.8M for year ended Dec 31, 2023.
- Basic and diluted EPS improved 50% YoY to -$3.48 from -$6.98.
- Cash and cash equivalents $8.7M at Dec 31, 2023, down from $22.1M at Dec 31, 2022.
- Collaboration progress: FluGen intranasal flu vaccine, Cancer Research Horizons glutaminase inhibitors, UPMC ovarian cancer AI study.
- Q4 net loss per share $0.74; company cited cash burn of $13.2M in operating activities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184324001695/0001171843-24-001695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184324001695/f8k_032824.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-001695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer